What’s Next? Five Things To Look Out For In March
Viatris Awaits Glatiramer Value Add PDUFA Date; EU Xolair Patent Expires
Generics Bulletin previews the most noteworthy and anticipated events for March 2024.

Generics Bulletin previews the most noteworthy and anticipated events for March 2024.